US-EN
Select Country
<br/>A broad range of imaging agents, procedures and devices that meet emerging medical challenges and facilitate clinical success <br/>One of the World's leading companies engaged in the development of new imaging solutions that address the evolving needs of patients <br/>Continuously invest in medical research and development, to provide innovative diagnostic products that match patients' needs <br/>A global partner with local resources. Everyday Bracco moves forward in all key diagnostic imaging modalities
1 2 3 4

Latest news

Bracco Imaging announces the first echocardiography imaging procedure in US with Lumason™ (sulfur hexafluoride lipid-type A microspheres) for injectable suspension

 

Press release

 

Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite

Bracco Diagnostic Inc. (BDI) today announced the availability of its innovative ISOVUE® (iopamidol injection) Imaging Bulk Package.

Press release

TRUTH Study

Click here to learn about the TRUTH1 Study.
Reference 1. Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study). AJNR Am J Neuroradiol. 2014 Oct 9. [Epub ahead of print]

Congress calendar

From September 10 to 11, 2015
Chicago, IL

ICUS Bubble Conference

From September 18 to 19, 2015
Washington, D.C.

ASNC

Educational Events

AIMS

Established to compare various clinical approaches for targeted diagnostic imaging.

Read more

BAMRIS

Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more